Guenter Janhofer - Chief Scientific Officer at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
QNCX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Guenter Janhofer since 11 Mar 2025

Holdings reported by Guenter Janhofer for Quince Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15,008 $14,108 $0.9400 23 Oct 2023 Direct
Employee Stock Option (right to buy) 300,000 23 Oct 2023 Direct Common Stock

Transactions reported by Guenter Janhofer for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.